New approaches to treatment of osteogenesis imperfecta.
D000293:Adolescent; D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D001842:Bone and Bones / Q000378:metabolism; D002116:Calcitonin / Q000627:therapeutic use*; D002118:Calcium / Q000378:metabolism; D002127:Calcium Isotopes; D002417:Cattle; D002648:Child; D002675:Child, Preschool; D011756:Diphosphates / Q000378:metabolism; D005260:Female; D005459:Fluorides / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008277:Magnesium Oxide / Q000627:therapeutic use*; D008875:Middle Aged; D010013:Osteogenesis Imperfecta / Q000188:drug therapy*; D012474:Salmon; D013552:Swine
D045930:Anabolic Agents; D002127:Calcium Isotopes; D011756:Diphosphates; D012739:Gonadal Steroid Hormones; D008277:Magnesium Oxide; D002116:Calcitonin; D005459:Fluorides; D002118:Calcium